This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Health product recall

Immulite Systems

Starting date:
November 16, 2012
Posting date:
December 24, 2012
Type of communication:
Medical Device Recall
Subcategory:
Medical Device
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Medical Devices
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-25879

Recalled Products

  1. Immulite 2000 System IGF-1 (Insulin-like Growth Hormone) Assay
  2. Immulite System IGF-1 (Insulin-like Growth Hormone) Assay
  3. Immulite 1000 System IGF-1 Assay

Reason

There is a positive shift in patient medians of approximately 20% with the igf-I assay. An initial positive shift of approximately 15% occurred with immulite 2000/immulite 2000 xpi kit lot 441 (released december 2009), and in mid-2011 an additional positive shift of approximately 5% was observed with immulite 2000/immulite 2000 xpi kit lot 469 (released july 2011), leading to the total positive shift of approximately 20%.

Affected products

A. Immulite 2000 System IGF-1 (Insulin-like Growth Hormone) Assay

Lot or serial number

Lot 441 to 492

Model or catalog number

L2KGF2

Companies
Manufacturer
Siemens Healthcare Diagnostics Products Limited

B. Immulite System IGF-1 (Insulin-like Growth Hormone) Assay

Lot or serial number

Lot 315 to 335

Model or catalog number

LKGF1

Companies
Manufacturer
Siemens Healthcare Diagnostics Products Limited

C. Immulite 1000 System IGF-1 Assay

Lot or serial number

Lot 315 to 335

Model or catalog number

LKGF1

Companies
Manufacturer
Siemens Healthcare Diagnostics Products Limited